Therefore, whether CDC27 can promote metastasis via modulating certain potential downstream molecular in CRC, and whether there is a correlation between CDC27 and its downstream molecular in clinical samples, remain to be determined in future studies. This evidence concerns the gene CDC27 and colorectal carcinoma.